Riqiang Luo

536 total citations
8 papers, 62 citations indexed

About

Riqiang Luo is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Riqiang Luo has authored 8 papers receiving a total of 62 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 2 papers in Rheumatology. Recurrent topics in Riqiang Luo's work include Pulmonary Hypertension Research and Treatments (5 papers), Systemic Sclerosis and Related Diseases (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Riqiang Luo is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Systemic Sclerosis and Related Diseases (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Riqiang Luo collaborates with scholars based in China. Riqiang Luo's co-authors include Yang Cui, Yuan Feng, Jinping Zheng, Xiao Zhang, Hui Zeng, Guangfeng Zhang, Xiao Zhang, Fei Liang, Xiao Zhang and Haobo Lin and has published in prestigious journals such as Arthritis Research & Therapy, British Journal of Radiology and Modern Rheumatology.

In The Last Decade

Riqiang Luo

8 papers receiving 61 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riqiang Luo China 6 34 28 25 9 8 8 62
Jolanta Gąsior Poland 6 59 1.7× 16 0.6× 53 2.1× 6 0.8× 8 80
Bogdan Feciche Romania 6 36 1.1× 5 0.2× 18 0.7× 2 0.2× 14 1.8× 19 97
J Despaux France 7 42 1.2× 14 0.5× 49 2.0× 7 0.8× 2 0.3× 12 102
Elżbieta Kuźma-Mroczkowska Poland 6 13 0.4× 10 0.4× 26 1.0× 1 0.1× 13 1.6× 11 77
Zahraa I. Selim Egypt 5 13 0.4× 8 0.3× 34 1.4× 1 0.1× 3 0.4× 12 64
Sigita Stropuvienë Lithuania 5 5 0.1× 10 0.4× 48 1.9× 4 0.4× 11 1.4× 10 85
Ursula‐Henrike Wienhues‐Thelen Germany 6 9 0.3× 14 0.5× 10 0.4× 3 0.3× 70 8.8× 8 102
Leena Martola Finland 6 23 0.7× 20 0.7× 14 0.6× 28 3.1× 3 0.4× 14 110
Adina Pop‐Moldovan Romania 6 7 0.2× 8 0.3× 6 0.2× 16 1.8× 35 4.4× 11 80
Jonathan J. Hogan United States 4 24 0.7× 17 0.6× 5 0.2× 16 2.0× 9 81

Countries citing papers authored by Riqiang Luo

Since Specialization
Citations

This map shows the geographic impact of Riqiang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riqiang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riqiang Luo more than expected).

Fields of papers citing papers by Riqiang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riqiang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riqiang Luo. The network helps show where Riqiang Luo may publish in the future.

Co-authorship network of co-authors of Riqiang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Riqiang Luo. A scholar is included among the top collaborators of Riqiang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riqiang Luo. Riqiang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zhang, Xiao, et al.. (2021). Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus. Cardiology in the Young. 31(10). 1619–1624. 11 indexed citations
2.
Li, Ling, Riqiang Luo, Ting Xu, et al.. (2021). Diagnostic efficacy of joint ultrasonography, dual-energy computed tomography and minimally invasive arthroscopy on knee gouty arthritis, a comparative study. British Journal of Radiology. 94(1121). 20200493–20200493. 5 indexed citations
3.
Zhang, Xiao, et al.. (2019). The effects of oral treatment for systemic sclerosis related pulmonary arterial hypertension: A systematic review and meta-analysis. Modern Rheumatology. 31(1). 151–161. 10 indexed citations
4.
Cui, Yang, et al.. (2016). Evaluation of treatments for sacroiliitis in spondyloarthropathy using the Spondyloarthritis Research Consortium Canada scoring system. Arthritis Research & Therapy. 18(1). 38–38. 13 indexed citations
5.
Zhang, Guangfeng, Ting Xu, Hongwei Zhang, et al.. (2015). [Randomized control multi-center clinical study of mycophenolate mofetil and cyclophosphamide in the treatment of connective tissue disease related interstitial lung disease].. PubMed. 95(45). 3641–5. 9 indexed citations
6.
Li, Ling, et al.. (2010). [Effect of recombinant human tumor necrosis factor receptor type II-Fc fusion protein antibody on cytokines and bone metabolism in patients with juvenile idiopathic arthritis].. PubMed. 90(31). 2205–8. 2 indexed citations
7.
Zhang, Xiao, et al.. (2009). [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].. PubMed. 89(41). 2934–7. 4 indexed citations
8.
Luo, Riqiang, et al.. (2008). [Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension].. PubMed. 28(10). 1860–3. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026